TrialCancer medicine2023

Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non-small cell lung cancer: A multicenter Phase 2 clinical trial.

Tomoaki Sonoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.